237435-24-4 Usage
Uses
Used in Pharmaceutical Industry:
2,6-diphenylpyrrolo[3,2-d]pyrimidin-4-ol is used as a potential drug candidate for its potential anticancer and antiviral properties. Its unique structure and substitution pattern may contribute to specific medicinal properties, warranting further investigation into its biological activities and mechanisms of action.
Used in Anticancer Applications:
In the field of oncology, 2,6-diphenylpyrrolo[3,2-d]pyrimidin-4-ol is utilized as a potential anticancer agent. Its pharmacological properties may allow it to target and inhibit the growth of cancer cells, offering a novel therapeutic approach for cancer treatment.
Used in Antiviral Applications:
2,6-diphenylpyrrolo[3,2-d]pyrimidin-4-ol is also considered for its potential antiviral applications. Its ability to interfere with viral replication and infection processes could provide a new avenue for the development of antiviral drugs, particularly against viruses that are resistant to existing treatments.
Further research is necessary to fully understand the potential of 2,6-diphenylpyrrolo[3,2-d]pyrimidin-4-ol as a pharmaceutical agent and to explore its specific applications in various therapeutic areas.
Check Digit Verification of cas no
The CAS Registry Mumber 237435-24-4 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,3,7,4,3 and 5 respectively; the second part has 2 digits, 2 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 237435-24:
(8*2)+(7*3)+(6*7)+(5*4)+(4*3)+(3*5)+(2*2)+(1*4)=134
134 % 10 = 4
So 237435-24-4 is a valid CAS Registry Number.
237435-24-4Relevant academic research and scientific papers
Compounds and methods which modulate feeding behavior and related diseases
-
, (2008/06/13)
There are provided compounds, compositions and methods of use thereof in the modulation of feeding behavior, obesity, diabetes, cancer (tumor), inflammatory disorders, depression, stress related disorders, Alzheimer's disease and other disease conditions.
Structure-activity relationships of a series of pyrrolo[3,2-d]pyrimidine derivatives and related compounds as neuropeptide Y5 receptor antagonists
Norman,Chen,Chen,Fotsch,Hale,Han,Hurt,Jenkins,Kincaid,Liu,Lu,Moreno,Santora,Sonnenberg,Karbon
, p. 4288 - 4312 (2007/10/03)
Neuropeptide Y (NPY) has been shown to play an important role in the regulation of food intake and energy balance. Pharmacological data suggests that the Y5 receptor subtype contributes to the effects of NPY on appetite, and therefore a Y5 antagonist might be a useful therapeutic agent for the treatment of obesity. In attempts to identify potential Y5 antagonists, a series of pyrrolo[3,2-d]pyrimidine derivatives was prepared and evaluated for their ability to bind to Y5 receptors in vitro. We report here the synthesis and initial structure-activity relationship investigations for this class of compounds. The target compounds were prepared by a variety of synthetic routes designed to modify both the substitution and the heterocyclic core of the pyrrolo[3,2-d]pyrimidine lead 1. In addition to identifying several potent Y5 antagonists for evaluation as potential antiobesity agents, a pharmacophore model for the human Y5 receptor is presented.
